2007Zhongguo linchuang yixueRequires access

Expression and Clinical Significance of CD105、CD34 in Human Glioma

Yong-peng Cui

Open publisher page 0 citations

Abstract

Objective:To compare the expression of CD105,CD34 and investigate the relationship between the microvessel density (MVD) marked with anti-CD105,anti-CD34 antibody and the clinicopathologie grade in human gIioma.Methods:Im- munohistochemical method was used to analyze the expression of CD105,CD34 in 46 case of human glioma.Results..the expres- sion of CD105,CD34 in human glioma is higher than that of the normal brain issue.The expression of CD105 is more specifici- ty than that of CD34 in human glioma.MVD marked with CD105,CD34 antibody were positively correlated with the malignant grades(r_s=0.824,P<0.01;r_s=0.675,P<0.01)in glioma.Conclusion:The expression of CD105 is more specificity than that of CD34 in human glioma.MVD marked with CD105 antibody may be a valuable marker for judging the malignant grades and predicting the risk of development in glioma,and this marker is superior to MVD marked with CD34.

About this research paper

What this paper is about

Objective:To compare the expression of CD105,CD34 and investigate the relationship between the microvessel density (MVD) marked with anti-CD105,anti-CD34 antibody and the clinicopathologie grade in human gIioma.Methods:Im- munohistochemical method was used to analyze the expression of CD105,CD34 in 46 case of human glioma.Results..the expres- sion of CD105,CD34 in human glioma is higher than that of the normal brain issue.The expression of CD105 is more specifici- ty than that of CD34 in human glioma.MVD marked with CD105,CD34 antibody were positively correlated with the malignant grades(r_s=0.824,P<0.01;r_s=0.675,P<0.01)in glioma.Conclusion:The expression of CD105 is more specificity than that of CD34 in human glioma.MVD marked with CD105 antibody may be a valuable marker for judging the malignant grades and predicting the risk of development in glioma,and this marker is superior to MVD marked with CD34.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To compare the expression of CD105,CD34 and investigate the relationship between the microvessel density (MVD) marked with anti-CD105,anti-CD34 antibody and the clinicopathologie grade in human gIioma.Methods:Im- munohistochemical method was used to analyze the expression of CD105,CD34 in 46 case of human glioma.Results..the expres- sion of CD105,CD34 in human glioma is higher than that of the normal brain issue.The expression of CD105 is more specifici- ty than that of CD34 in human glioma.MVD marked with CD105,CD34 antibody were positively correlated with the malignant grades(r_s=0.824,P<0.01;r_s=0.675,P<0.01)in glioma.Conclusion:The expression of CD105 is more specificity than that of CD34 in human glioma.MVD marked with CD105 antibody may be a valuable marker for judging the malignant grades and predicting the risk of development in glioma,and this marker is superior to MVD marked with CD34.

Key concepts: Endoglin, CD34, Glioma, Medicine, Pathology, Cancer research, Stem cell, Biology

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression and Clinical Significance of CD105、CD34 in Human Glioma — Research Paper | ScholarLens